Published in Lab Business Week, January 21st, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Avanir Pharmaceuticals.
Report 1: Avanir Pharmaceuticals (AVNR) has been selected for addition to the NASDAQ Biotechnology Index, which was effective at the market's opening on Monday, November 20, 2006.
The NASDAQ Biotechnology Index was launched in 1993 and includes securities of NASDAQ-listed companies that meet minimum requirements, including market value, average daily share volume, and seasoning as a public company, among other criteria. Avanir's inclusion was based...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.